Swiss National Bank Charles River Laboratories International, Inc. Transaction History

Swiss National Bank

$150 Billion
Q3 2024

A detailed history of Swiss National Bank transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Swiss National Bank holds 152,800 shares of CRL stock, worth $30.1 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

152,800

Previous 152,100 0.46%

Holding current value

$30.1 Million

Previous $31.4 Million 4.2%

% of portfolio

0.02%

Previous 0.02%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$187.96 - $245.29 $131,572 - $171,703	700 Added 0.46%	152,800 $30.1 Million
Q2 2024 Aug 08, 2024	SELL	$206.39 - $268.73 $309,585 - $403,095	-1,500 Reduced 0.98%	152,100 $31.4 Million
Q1 2024 May 07, 2024	SELL	$203.52 - $273.43 $1.36 Million - $1.83 Million	-6,700 Reduced 4.18%	153,600 $41.6 Million
Q4 2023 Feb 06, 2024	SELL	$164.52 - $238.84 $723,888 - $1.05 Million	-4,400 Reduced 2.67%	160,300 $37.9 Million
Q3 2023 Nov 08, 2023	SELL	$194.44 - $217.61 $3.93 Million - $4.4 Million	-20,200 Reduced 10.92%	164,700 $32.3 Million
Q2 2023 Aug 09, 2023	SELL	$183.71 - $210.25 $3.1 Million - $3.55 Million	-16,900 Reduced 8.37%	184,900 $38.9 Million
Q1 2023 May 10, 2023	SELL	$191.89 - $259.92 $940,260 - $1.27 Million	-4,900 Reduced 2.37%	201,800 $40.7 Million
Q4 2022 Feb 08, 2023	SELL	$197.11 - $250.07 $2.66 Million - $3.38 Million	-13,500 Reduced 6.13%	206,700 $45 Million
Q3 2022 Nov 09, 2022	BUY	$182.44 - $250.54 $273,660 - $375,810	1,500 Added 0.69%	220,200 $43.3 Million
Q2 2022 Aug 09, 2022	BUY	$204.13 - $302.4 $20,413 - $30,239	100 Added 0.05%	218,700 $46.8 Million
Q1 2022 May 09, 2022	BUY	$255.51 - $362.11 $6.9 Million - $9.78 Million	27,000 Added 14.09%	218,600 $62.1 Million
Q4 2021 Feb 08, 2022	SELL	$351.38 - $448.68 $2.49 Million - $3.19 Million	-7,100 Reduced 3.57%	191,600 $72.2 Million
Q3 2021 Nov 08, 2021	SELL	$372.64 - $458.3 $2.27 Million - $2.8 Million	-6,100 Reduced 2.98%	198,700 $82 Million
Q2 2021 Aug 06, 2021	BUY	$294.17 - $371.65 $26.8 Million - $33.9 Million	91,100 Added 80.12%	204,800 $75.8 Million
Q1 2021 May 07, 2021	BUY	$249.67 - $299.48 $349,538 - $419,272	1,400 Added 1.25%	113,700 $33 Million
Q4 2020 Feb 05, 2021	BUY	$222.0 - $252.62 $22,200 - $25,262	100 Added 0.09%	112,300 $28.1 Million
Q3 2020 Nov 09, 2020	BUY	$175.56 - $226.45 $298,452 - $384,965	1,700 Added 1.54%	112,200 $25.4 Million
Q2 2020 Aug 05, 2020	BUY	$118.84 - $189.72 $1.88 Million - $3 Million	15,800 Added 16.68%	110,500 $19.3 Million
Q1 2020 May 08, 2020	BUY	$98.9 - $178.34 $128,570 - $231,842	1,300 Added 1.39%	94,700 $12 Million
Q4 2019 Feb 06, 2020	BUY	$126.05 - $152.76 $201,680 - $244,416	1,600 Added 1.74%	93,400 $14.3 Million
Q3 2019 Nov 12, 2019	BUY	$125.07 - $143.67 $262,647 - $301,707	2,100 Added 2.34%	91,800 $12.2 Million
Q2 2019 Aug 02, 2019	BUY	$123.4 - $148.55 $259,140 - $311,955	2,100 Added 2.4%	89,700 $12.7 Million
Q1 2019 May 10, 2019	BUY	$104.82 - $146.73 $283,014 - $396,171	2,700 Added 3.18%	87,600 $12.7 Million
Q4 2018 Feb 13, 2019	BUY	$105.09 - $137.23 $136,617 - $178,399	1,300 Added 1.56%	84,900 $9.61 Million
Q3 2018 Nov 08, 2018	BUY	$112.11 - $134.54 $89,688 - $107,632	800 Added 0.97%	83,600 $11.2 Million
Q1 2018 May 04, 2018	BUY	$98.19 - $115.2 $166,923 - $195,840	1,700 Added 2.1%	82,800 $8.84 Million
Q4 2017 Feb 07, 2018	BUY	$100.43 - $118.09 $190,817 - $224,371	1,900 Added 2.4%	81,100 $8.88 Million
Q3 2017 Nov 03, 2017	BUY	$96.72 - $109.26 $7.66 Million - $8.65 Million	79,200	79,200 $8.56 Million

Others Institutions Holding CRL

# of Institutions

691

Shares Held

52.3M

Call Options Held

226K

Put Options Held

410K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Charles River Laboratories International, Inc. Transaction History